0000950142-12-000844.txt : 20120405 0000950142-12-000844.hdr.sgml : 20120405 20120405185335 ACCESSION NUMBER: 0000950142-12-000844 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120404 FILED AS OF DATE: 20120405 DATE AS OF CHANGE: 20120405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN DOV A MD CENTRAL INDEX KEY: 0001120478 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52120 FILM NUMBER: 12746815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC. CENTRAL INDEX KEY: 0001368514 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 562590442 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 65 COMMERCE WAY CITY: HACKENSACK STATE: NJ ZIP: 07601 BUSINESS PHONE: (201) 478-5552 MAIL ADDRESS: STREET 1: 65 COMMERCE WAY CITY: HACKENSACK STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: R&R ACQUISITION VI, INC DATE OF NAME CHANGE: 20060707 4 1 es1200529_4-goldstein.xml OWNERSHIP DOCUMENT X0305 4 2012-04-04 0 0001368514 ADMA BIOLOGICS, INC. NONE 0001120478 GOLDSTEIN DOV A MD 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10106 1 0 0 0 Stock Option 9.60 2012-04-04 4 A 0 13258 0 A 2022-04-03 Common Stock 13258 13258 D 25% of these options will become exercisable on April 4, 2013, and the remainder will become exercisable in equal monthly installments on the 29th of each month until April 4, 2016. These stock options are held by Dr. Goldstein for the benefit of Aisling Capital LLC. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein. /s/ Dov A. Goldstein 2012-04-05